Repligen Appoints Carrie Eglinton Manner to Board of Directors
June 15, 2020
WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over 23 years of leadership experience across multiple disciplines. She currently serves as Senior Vice President, Advanced Diagnostics at Quest Diagnostics (NYSE:DGX), the world’s leading [...]
June 15, 2020
Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System CARLSBAD, Calif. -- The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to identify low-grade glioma (LGG) patients with isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) [...]
June 15, 2020
Corning’s pre-coated Matrigel matrix-3D plates streamline workflows and deliver a more consistent and convenient solution for high throughput environments Corning Incorporated today announced the launch of Corning® Matrigel® matrix-3D plates, pre-dispensed with Matrigel matrix to provide a more consistent and convenient, ready-to-use cell culture option to support organoid and spheroid culture models. This new 3D tool [...]
BIT BIO SECURES $41.5 MILLION OF FUNDING FROM TOP LIFE SCIENCES INVESTORS
June 13, 2020
Rick Klausner, Bob Nelsen, and Jim Tananbaum team up with Bit Bio to uncover the “operating system of life” and accelerate the company’s drive towards industrial-scale manufacturing of all human cells CAMBRIDGE — Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells for the wellb eing of humanity, today announces the close [...]
June 12, 2020
Heerlen, NL Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces that it has reached agreement to acquire Erber Group for an enterprise value of €980m. The value of the transaction represents an EV/EBITDA multiple of about 14x the 2020 EBITDA (fiscal year ending September 2020). The transaction – which excludes [...]
Protein Stable Launches Innovative System for Protein Engineering and Antibody Formulation
June 12, 2020
Protein Stable launches its first product to aid in protein engineering-the SUPR-CM. With technology from Applied Photophysics and Fluorescence Innovations, the SUPR-CM offers the highest quality system for biophysics and biopharmaceutical research. The SUPR- CM is a high throughput protein stability measurement system with extensive applications in protein stability screening for formulation development and protein engineering. [...]
June 11, 2020
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced the signing of three new European distributor agreements to promote HTG products and services in Nordic and Eastern European Countries with BioNordika (Denmark), Explorea (Czech Republic), and ELTA 90 (Bulgaria). “Expanding and [...]
June 11, 2020
LONDON -- Synthace Ltd, the company behind Antha, the cloud-based software platform for automating and improving the success rate of biological processes, and the Tecan Group (SIX Swiss Exchange: TECN) announce a partnership to deepen the integration between Synthace’s Antha software and Tecan’s Te-Chrom™ automated chromatography system to unlock the full potential of miniaturized protein purification. The new [...]
June 11, 2020
Project Will Evolve Data Sharing Paradigm with the Goal of Rapidly Bringing Data from ongoing Clinical Trials to the Research Community BOSTON, MANHATTAN BEACH, CALIF. – Seven Bridges, the industry-leading bioinformatics ecosystem provider, today announced that it has been selected by the Pancreatic Cancer Action Network (PanCAN) to build a customized, integrated health data platform [...]
Twist Bioscience Expands Offering of Synthetic SARS-CoV-2 RNA Controls
June 11, 2020
OUTH SAN FRANCISCO, Calif.-- Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the addition of four new synthetic SARS-CoV-2 RNA Controls for the development, verification, and ongoing validation of diagnostic tests. The controls include new variants of SARS-CoV-2, the [...]

